Doctor V Limited - Period Ending 2023-12-31

Doctor V Limited - Period Ending 2023-12-31


Doctor V Limited 12865641 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is is that of the provision of plastic, reconstructive and aesthetic surgery Digita Accounts Production Advanced 6.30.9574.0 true true 12865641 2023-01-01 2023-12-31 12865641 2023-12-31 12865641 bus:OrdinaryShareClass1 2023-12-31 12865641 core:CurrentFinancialInstruments 2023-12-31 12865641 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 12865641 core:OfficeEquipment 2023-12-31 12865641 bus:SmallEntities 2023-01-01 2023-12-31 12865641 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 12865641 bus:FullAccounts 2023-01-01 2023-12-31 12865641 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 12865641 bus:RegisteredOffice 2023-01-01 2023-12-31 12865641 bus:Director1 2023-01-01 2023-12-31 12865641 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 12865641 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 12865641 core:OfficeEquipment 2023-01-01 2023-12-31 12865641 countries:AllCountries 2023-01-01 2023-12-31 12865641 2022-12-31 12865641 core:OfficeEquipment 2022-12-31 12865641 2022-01-01 2022-12-31 12865641 2022-12-31 12865641 bus:OrdinaryShareClass1 2022-12-31 12865641 core:CurrentFinancialInstruments 2022-12-31 12865641 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 12865641 core:OfficeEquipment 2022-12-31 12865641 bus:OrdinaryShareClass1 2022-01-01 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12865641

Doctor V Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2023

 

Doctor V Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Doctor V Limited

Company Information

Director

Dr Veerle Karine Rotsaert

Registered office

11A West Halkin Street
Belgravia
London
SW1X 8JL

Accountants

Thorntons Accounting Limited
Chartered Certified Accountants
176-178 Pontefract Road
Cudworth
Barnsley
South Yorkshire
S72 8BE

 

Doctor V Limited

(Registration number: 12865641)
Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

835

951

Current assets

 

Debtors

5

63,805

109,137

Cash at bank and in hand

 

213,122

87,381

 

276,927

196,518

Creditors: Amounts falling due within one year

6

(219,681)

(85,846)

Net current assets

 

57,246

110,672

Net assets

 

58,081

111,623

Capital and reserves

 

Called up share capital

7

1,000

1,000

Retained earnings

57,081

110,623

Shareholders' funds

 

58,081

111,623

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 18 March 2024
 

.........................................
Dr Veerle Karine Rotsaert
Director

 

Doctor V Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
11A West Halkin Street
Belgravia
London
SW1X 8JL

These financial statements were authorised for issue by the director on 18 March 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Doctor V Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

10% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Doctor V Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 5 (2022 - 4).

 

Doctor V Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

4

Tangible assets

Office equipment
£

Total
£

Cost or valuation

At 1 January 2023

1,164

1,164

At 31 December 2023

1,164

1,164

Depreciation

At 1 January 2023

213

213

Charge for the year

116

116

At 31 December 2023

329

329

Carrying amount

At 31 December 2023

835

835

At 31 December 2022

951

951

5

Debtors

2023
£

2022
£

Trade debtors

1,632

8,940

Other debtors

43,681

100,197

Prepayments

18,492

-

63,805

109,137

6

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Trade creditors

17,863

26,376

Taxation and social security

11,641

18,419

Accruals and deferred income

2,640

2,200

Other creditors

187,537

38,851

219,681

85,846

 

Doctor V Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

7

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary of £1 each

1,000

1,000

1,000

1,000

         

8

Dividends

Interim dividends paid

   

2023
£

 

2022
£

Interim dividend of £65.00 (2022 - £38.00) per each Ordinary

 

65,000

 

38,000

         

9

Related party transactions

Director's remuneration

The director's remuneration for the year was as follows:

2023
£

2022
£

Remuneration

12,948

10,770